跳至主要内容
临床试验/CTRI/2015/03/005649
CTRI/2015/03/005649进行中(未招募)2 期

Clinical evaluation of the efficacy of Rajahpravartini Vati, Kanchanar Guggulu and Varunadi Kashaya in the management of Polycystic Ovary Syndrome (PCOS): A pilot study - IMR-PCOS-TVM

Central Council for Research in Ayurvedic Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
进行中(未招募)
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Hyperandrogenism clinically (Hirsutism)/ or biochemically (elevated serum testosterone concentrations)
  • Oligomenorrhea (cycles of 35 days or longer)/ Amenorrhea (no menses in the last 6 months) after negative screening pregnancy test
  • Multiple cysts (more than 10) in the ovary
  • Able to comply with the requirements of the study
  • Able and willing to provide signed informed consent

排除标准

  • Age-younger than 18 or older than 40 yr
  • History of primary amenorrhea
  • Secondary amenorrhea due to lactation
  • Pregnancy/ Planned pregnancy during the treatment period
  • Not associated with any organic reproductive system abnormalities (Excluded clinically and Radiological), pelvic inflammatory disease, Hydrosalpinx, endometriosis, adenomyosis, fibroid uterus, carcinoma of reproductive organ, etc.
  • Current or previous (within the last 3 months) use of oral contraceptives, glucocorticoids, anti-androgens, ovulation induction agents, antidiabetic and anti-obesity drugs, or other hormonal drugs.
  • Subjects with metabolic and endocrinal disorders like- diabetes mellitus, chronic Liver disease, renal disorder, high blood pressure, hypo & hyperthyroidism, etc.
  • Ingestion of any investigational drugs within 4 weeks prior to study onset
  • No uterine bleeding in progesterone challenge test

研究者

相似试验